Swiss regulator approves Pfizer/BioNTech booster for 16 and up

SwissInfo

23 November 2021 - Swissmedic has approved the extension of COVID-19 boosters for the Pfizer/BioNTech vaccine to all people aged 16 and over. 

This now "clears the way" for wider use of the booster vaccination, it said.

Read Swiss Medic press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Vaccine , Switzerland , COVID-19